COPD is a progressive inflammatory process affecting both the airways and alveolar structures of the lungs. Exacerbations of COPD are episodes of acute worsening of this inflammatory process, often triggered by infections. The most severe exacerbations are characterized by substantial air trapping and inspiratory muscle overload, which leads to hypercapnic respiratory failure. Pharmacologic therapies focus on intense bronchodilator administration (usually by aerosol), corticosteroids, and antibiotics. Respiratory life support technologies are often needed for severe exacerbations and range from carefully titrated supplemental O2 administration to positive-pressure ventilation (both invasive and noninvasive). Future life support strategies will likely involve extracorporeal life support technologies.
Del VecchioL, PoleseG, PoggiR, RossiA. “Intrinsic” positive end-expiratory pressure in stable patients with chronic obstructive pulmonary disease. Eur Respir J, 1990; 3(1):74-80.
7.
HaluszkaJ, ChartrandDA, GrassinoAE, Milic-EmiliJ. Intrinsic PEEP and arterial PCO2 in stable patients with chronic obstructive pulmonary disease. Am Rev Respir Dis, 1990; 141(5 pt. 1):1194-1197.
8.
CampelloneJV. Respiratory muscle weakness in patients with critical illness neuromyopathies: a practical assessment. Crit Care Med, 2007; 35(9):2205-2206.
9.
ScholsAM, GoskerHR. The pathophysiology of cachexia in chronic obstructive pulmonary disease. Curr Opin Support Palliat Care, 2009; 3(4):282-287.
WhiteAJ, GompertzS, StockleyRA. Chronic obstructive pulmonary disease. 6: The etiology exacerbations of chronic obstructive pulmonary disease. Thorax, 2003; 58(1):73-80.
12.
EldridgeF, DavisJM. Effect of mechanical factors on respiratory work and ventilatory responses to CO2. J Appl Physiol, 1959; 14(5):721-726.
13.
RoussosC, FixleyM, GrossD, MacklemPT. Fatigue of the inspiratory muscles and their synergistic behavior. J Appl Physiol Respir Environ Exerc Physiol, 1979; 46(5):897-904.
14.
BellemareF, GrassinoA. Force reserve of the diaphragm in patients with chronic obstructive pulmonary disease. J Appl Physiol Respir Environ Exerc Physiol, 1983; 55(1 pt. 1):8-15.
15.
CohenCA, ZagelbaumG, GrossD, RoussosC, MacklemPT. Clinical manifestations of inspiratory muscle fatigue. Am J Med, 1982; 73(3):308-316.
16.
McKenzieDK, AllenGM, ButlerJE, GandeviaSC. Task failure with lack of diaphragm fatigue during inspiratory resistive loading in human subjects. J Appl Physiol (1985), 1997; 82(6):2011-2019.
17.
ZhuE, PetrofBJ, GeaJ, ComtoisN, GrassinoAE. Diaphragm muscle fiber injury after inspiratory resistive breathing. Am J Respir Crit Care Med, 1997; 155(3):1110-1116.
18.
BellemareF, GrassinoA. Effect pressure and timing of contraction on human diaphragm fatigue. J Appl Physiol Respir Environ Exerc Physiol, 1982; 53(5):1190-1195.
Milic-EmiliJ. Dynamic pulmonary hyperinflation and intrinsic PEEP: consequences and management in patients with chronic obstructive pulmonary disease. Recent Prog Med, 1990; 81(11):733-737.
21.
MacIntyreNR, McConnellR, ChengKC. Applied PEEP reduces the inspiratory load of intrinsic PEEP during pressure support. Chest, 1997; 111(1):188-193.
22.
MariniJJ, CulverBH, ButlerJ. Mechanical effect of lung inflation with positive pressure on cardiac function. Am Rev Respir Dis, 1981; 124(4):382-386.
23.
PinskyMR, GuimondJG. The effects of positive end-expiratory pressure on heart-lung interactions. J Crit Care, 1991; 6(1):1-15.
24.
WestJB, WagnerPD. Pulmonary gas exchange. Am J Respir Crit Care Med, 1998; 157(4 pt. 2):S82-S87.
25.
Global Initiative for Chronic Obstructive Lung Disease (GOLD) Report. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2022. https://goldcopd.org/2022-gold-reports.
26.
JinjuvadiaC, JinjuvadiaR, MandapakalaC, DurairajanN, LiangpunsakulS, SoubaniAO. Trends in outcomes, financial burden, and mortality for acute exacerbation of chronic obstructive pulmonary disease (COPD) in the United States from 2002 to 2010. COPD, 2017; 14(1):72-79.
27.
HajizadehN, GoldfeldK, CrothersK. What happens to patients with COPD with long-term oxygen treatment who receive mechanical ventilation for COPD exacerbation? A 1-year retrospective follow-up study. Thorax, 2015; 70(3):294-296.
28.
CellBR, MacNeeW. ATS ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J, 2004; 23(6):932-946.
29.
QuonBS, GanWQ, SinDD. Contemporary management of acute exacerbations of COPD; a systemic review and meta-analysis. Chest, 2008; 133(3):756-766.
30.
MacIntyreNR. Aerosol delivery through an artificial airway. Respir Care, 2002; 47(11):1279-1288.
31.
NiewoehnerDE, ErblandML, DeupreeRH, CollinsD, GrossNJ, LightRW, et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N Engl J Med, 1999; 340(25):1941-1947.
32.
AliaI, de la CalMA, EstebanA, AbellaA, FerrerR, MolinaF, et al. Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilator support. Arch Intern Med, 2011; 171(21):1939-1946.
33.
SivapalanP, IngebrigtsenTS, RasmussenDB, SørensenR, RasmussenCM, JensenCB, et al. COPD exacerbations: the impact of long versus short courses or oral corticosteroids on mortality and pneumonia: nationwide data on 67,000 patients with COPD followed for 12 months. BMJ Open Respir Res, 2019; 6(1):e000407.
34.
AnthonisenNT, ManfredaJ, WarrenCP, HershfieldES, HardingGK, NelsonNA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med, 1987; 106(2):196-204.
35.
MartinezFJ, HanMK, FlahertyK, CurtisJ. Role of infection and antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease. Expert Rev anti Infect Ther, 2006; 4(1):101-124.
36.
VollenweiderDJ, JarrettH, Steurer-SteyCA, Garcia-AymerichJ, PuahMA. Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 2012; 12:CD010257.
37.
WedzichaJ-C, MiravitllesM, HurstJR, CalverleyPM, AlbertRK, AnzuetoA, et al. Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Resp J, 2017; 49(3):1600791.
38.
PirainoT, MaddenM, RobertsKJ, LambertiJE, StricklandSL. Management of adult patients with oxygen in the acute care setting. Resp Care, 2022; 67(1):115-128.
39.
CortegianiA, LonghiniF, MadottoF, GroffP, ScalaR, CrimiC, et al. H. F.-AECOPD study investigators. High-flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multi-center non-inferiority randomized trial. Crit Care, 2020; 24(1):692.
40.
XuZ, ZhuL, ZhanJ, LiuL. The efficacy and safety of high-flow nasal cannula therapy in patients with COPD and type II respiratory failure: a meta-analysis and systematic review. Eur J Med Res, 2021; 26(1):122.
41.
BannerMJ, KirbyRR, MacIntyreNR. Patient and ventilatory work of breathing and ventilatory muscle loads at different levels of pressure support ventilation. Chest, 1991; 100(2):531-533.
42.
GoldsteinRS, De RosieJA, AvendanoMA, DolmageTE. Influence of noninvasive positive-pressure ventilation on inspiratory muscles. Chest, 1991; 99(2):408-415.
AmatoMB, MeadeMO, SlutskyAS, BrochardL, CostaEL, SchoenfeldDA, et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med, 2015; 372(8):747-755.
49.
NassarB. Should we be permissive with hypercapnia?. Ann Am Thorac Soc, 2022; 19(2):165-166.
50.
JubranA, Van de GraaffWB, TobinMJ. Variability of patient-ventilatory interaction with pressure support ventilation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 1995; 152(1):129-136.
51.
MacIntyreNR. Design features of modern mechanical ventilators. Clin Chest Med, 2016; 37(4):607-613.
52.
YounesM. Proportional assist ventilation, a new approach to ventilatory support. Am Rev Respir Dis, 1992; 145(1):114-120.
CaramezMP, BorgesJB, TucciMR, OkamotoVN, CarvalhoCRR, KacmarekRM, et al. Paradoxical responses to positive end-expiratory pressure in patients with airway obstruction during controlled ventilation. Crit Care Med, 2005; 33(7):1519-1528.
55.
HessDR. Noninvasive ventilation for acute respiratory failure. Respir Care, 2013; 58(6):950-972.
56.
BrochardL, ManceboJ, WysockiM, LofasoF, ContiG, RaussA, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med, 1995; 333(13):817-822.
57.
LindenauerPK, StefanMS, ShiehMS, PekowPS, RothbergMB, HillNS. Outcomes associated with invasive and noninvasive ventilation among patients hospitalized with exacerbations of chronic obstructive pulmonary disease. JAMA Intern Med, 2014; 174(12):1982-1993.
58.
StefanMS, NathansonBH, HigginsTL, SteingrubJS, LaguT, RothbergMB, et al. Comparative effectiveness of noninvasive and invasive ventilation in critically ill patients with acute exacerbation of chronic obstructive pulmonary disease. Crit Care Med, 2015; 43(7):1386-1394.
59.
RamFS, PicotJ, LightowlerJ, WedzichaJA. Noninvasive positive-pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 2004(1):Cd004104.
60.
MosherCL, WeberJM, BhargavS, AdagarlaS, NeelyML, PalmerSM, MacIntyreNR. Timing of treatment outcomes and risk factors for failure of BPAP in patients hospitalized for COPD exacerbation. Resp Care, 2022, in press.
61.
RochwergB, BrochardL, ElliottMW, HessD, HillNS, NavaS, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Resp J, 2017; 50(2):160426.
62.
TanD, WallineJH, LingB, XuY, SunJ, WangB, et al. High-flow nasal cannula oxygen therapy versus noninvasive ventilation for chronic obstructive pulmonary disease patients after extubation: a multi-center, randomized controlled trial. Crit Car, 2020; 24(1):489-499.
63.
AzziM, AboabJ, AlvisetS, UshmorovaD, FerreiraL, IoosV, et al. Extracorporeal CO2 removal in acute exacerbation of COPD unresponsive to noninvasive ventilation. BMJ Open Respir Res, 2021; 8(1).
64.
ZanellaA, CastagnaL, SalernoD, ScaravilliV, El Sayed DeabSAEA, MagniF, et al. Respiratory electrodialysis. A novel, highly efficient extracorporeal CO2 removal technique. Am J Respir Crit Care Med, 2015; 192(6):719-726.
